99 related articles for article (PubMed ID: 1666667)
1. [In vitro bactericidal effect of temafloxacin and tosufloxacin against streptococci].
Aubert G; Pozzetto B; Dorche G
Pathol Biol (Paris); 1991 Dec; 39(10):1002-5. PubMed ID: 1666667
[TBL] [Abstract][Full Text] [Related]
2. [In vitro effect of new fluoroquinolones and betalactamines combinations against enterococci].
Aubert G; Pozzetto B; Dorche G
Pathol Biol (Paris); 1991 Dec; 39(10):1006-8. PubMed ID: 1666668
[TBL] [Abstract][Full Text] [Related]
3. [In vitro activity of trovafloxacin in 238 respiratory pathogens].
Alarcón T; Domingo D; Prieto N; Sánchez S; López-Brea M
Rev Esp Quimioter; 1998 Mar; 11(1):47-51. PubMed ID: 9795289
[TBL] [Abstract][Full Text] [Related]
4. [Antibiotics susceptibility of Streptococcus and Enterococcus: data of Onerba network].
Vachée A; Varon E; Jouy E; Meunier D;
Pathol Biol (Paris); 2009 May; 57(3):240-4. PubMed ID: 18343047
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of gemifloxacin compared with other antimicrobial agents against recent clinical isolates of streptococci.
Ieven M; Goossens W; De Wit S; Goossens H
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():51-3. PubMed ID: 10824033
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of novel rifamycins against gram-positive clinical isolates.
Murphy CK; Karginova E; Sahm D; Rothstein DM
J Antibiot (Tokyo); 2007 Sep; 60(9):572-6. PubMed ID: 17917240
[TBL] [Abstract][Full Text] [Related]
7. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
Fernandes PB; Swanson RN
Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of gemifloxacin (SB-265805) compared to eleven other antimicrobial agents against streptococcal isolates, excluding Streptococcus pneumoniae.
Kerawala M; Ambler JE; Lee PY; Drabu YJ
Eur J Clin Microbiol Infect Dis; 2001 Apr; 20(4):271-5. PubMed ID: 11399019
[TBL] [Abstract][Full Text] [Related]
9. [Activity of 5 fluoroquinolones on hospital Gram-negative bacilli with different sensitivities to pefloxacin].
Aubert G; Puech C; Lucht F; Loboguerrero M; Denis M; Dorche G
Pathol Biol (Paris); 1989 Oct; 37(8):881-7. PubMed ID: 2515519
[TBL] [Abstract][Full Text] [Related]
10. Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.
Brigante GR; Luzzaro FA; Pini B; Lombardi G; Sokeng G; Toniolo AQ
BMC Microbiol; 2007 May; 7():46. PubMed ID: 17521437
[TBL] [Abstract][Full Text] [Related]
11. [In vitro antibacterial activity of a new fluoroquinolone, temafloxacin, against hospital isolates. Results of a multicenter study].
Soussy CJ; Morel C; Kitzis MD; Meyran M; Brun Y; Joly-Guillou ML; Dabernat H; Chanal M; Courtieu AL; Derlot E
Pathol Biol (Paris); 1991 May; 39(5):403-9. PubMed ID: 1881670
[TBL] [Abstract][Full Text] [Related]
12. Bactericidal activity of trovafloxacin (CP-99,219).
Morrissey I
J Antimicrob Chemother; 1996 Dec; 38(6):1061-6. PubMed ID: 9023654
[TBL] [Abstract][Full Text] [Related]
13. Antistreptococcal activity of Sch 34343, a new penem antibiotic.
Yu PK; Washington JA
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():67-71. PubMed ID: 3928578
[TBL] [Abstract][Full Text] [Related]
14. Numerical taxonomy of Streptococcus.
Bridge PD; Sneath PH
J Gen Microbiol; 1983 Mar; 129(3):565-97. PubMed ID: 6409982
[TBL] [Abstract][Full Text] [Related]
15. Penicillin tolerance among oral streptococci.
Holbrook WP; Olafsdóttir D; Magnússon HB; Benediktsdóttir E
J Med Microbiol; 1988 Sep; 27(1):17-22. PubMed ID: 3050106
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal index: a new way to assess quinolone bactericidal activity in vitro.
Morrissey I
J Antimicrob Chemother; 1997 Jun; 39(6):713-7. PubMed ID: 9222039
[TBL] [Abstract][Full Text] [Related]
17. Structures of existing and new quinolones and relationship to bactericidal activity against Streptococcus pneumoniae.
Mitsuyama J
J Antimicrob Chemother; 1999 Aug; 44(2):201-7. PubMed ID: 10473226
[TBL] [Abstract][Full Text] [Related]
18. Quinolone-resistance mechanisms and in vitro susceptibility patterns among European isolates of Streptococcus mitis, Streptococcus sanguis, and Streptococcus pneumoniae.
Schmitz FJ; Fisher A; Boos M; Mayer S; Milatovic D; Fluit AC
Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):219-22. PubMed ID: 11347679
[No Abstract] [Full Text] [Related]
19. In-vitro activity of sparfloxacin, pefloxacin, ciprofloxacin and temafloxacin against clinical isolates of Acinetobacter spp.
Joly-Guillou ML; Bergogne-Bérézin E
J Antimicrob Chemother; 1992 Apr; 29(4):466-8. PubMed ID: 1318878
[No Abstract] [Full Text] [Related]
20. Antimicrobial activities of two investigational fluoroquinolones (CI-960 and E4695) against over 100 Legionella sp. isolates.
Gooding BB; Erwin ME; Barrett MS; Johnson DM; Jones RN
Antimicrob Agents Chemother; 1992 Sep; 36(9):2049-50. PubMed ID: 1329642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
